335 filings
Page 2 of 17
SC 14D9/A
mytpps3944m qetm
22 Apr 21
Tender offer solicitation (amended)
9:13am
SC 14D9/A
172mo0m zss
13 Apr 21
Tender offer solicitation (amended)
8:05am
SC TO-T/A
7f39zwmj12
13 Apr 21
Third party tender offer statement (amended)
7:07am
SC 14D9/A
wwmpx2g
7 Apr 21
Tender offer solicitation (amended)
12:00am
SC TO-T/A
a6ytwkk
6 Apr 21
Third party tender offer statement (amended)
5:28pm
SC 14D9
ynhhx t83
25 Mar 21
Tender offer solicitation
7:06am
SC TO-T
gxfa 8kxzizprqra6p
25 Mar 21
Third party tender offer statement
7:02am
SC TO-C
hq8znk62m
18 Mar 21
Information about tender offer
5:19pm
SC TO-C
4v3top
17 Mar 21
Information about tender offer
4:56pm
SC TO-C
u3p4j t68e
15 Mar 21
Information about tender offer
5:11pm
SC14D9C
ga5rbd pckba
15 Mar 21
Written communication relating to third party tender offer
5:04pm
8-K
iktkx1
15 Mar 21
Entry into a Material Definitive Agreement
5:01pm
SC14D9C
u1z4 9v04mvlnlre
15 Mar 21
Written communication relating to third party tender offer
9:17am
SC14D9C
9h1q6b7o
15 Mar 21
Written communication relating to third party tender offer
9:15am
8-K
kromd37byw35jp4n
15 Mar 21
Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021
9:12am
SC TO-C
mnkpg79x5hxhp4rb h7
15 Mar 21
Information about tender offer
7:01am
8-K
u8j92l2pdgccfznc9
25 Feb 21
GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
4:08pm
8-K
acn6g0vsvnwo89hcp
24 Feb 21
Departure of Directors or Certain Officers
4:31pm
8-K
3xtp9x iyxvs
11 Jan 21
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
4:11pm